PHTF1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.452600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.314200E-01
Normal-vs-Stage2
8.594600E-01
Normal-vs-Stage3
3.563600E-01
Normal-vs-Stage4
9.877600E-01
Stage1-vs-Stage2
8.929400E-01
Stage1-vs-Stage3
4.757200E-01
Stage1-vs-Stage4
7.933600E-01
Stage2-vs-Stage3
2.646200E-01
Stage2-vs-Stage4
8.255600E-01
Stage3-vs-Stage4
2.726600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.528600E-01
Normal-vs-AfricanAmerican
5.926800E-01
Normal-vs-Asian
4.279200E-01
Caucasian-vs-AfricanAmerican
2.076800E-01
Caucasian-vs-Asian
2.389800E-01
AfricanAmerican-vs-Asian
1.015030E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.416600E-01
Normal-vs-Female
9.883800E-01
Male-vs-Female
2.184200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.276000E-01
Normal-vs-Age(41-60Yrs)
7.536600E-01
Normal-vs-Age(61-80Yrs)
7.379000E-01
Normal-vs-Age(81-100Yrs)
2.614800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.215000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.614200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.673000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.268200E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.037940E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.534820E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.312600E-01
Normal-vs-Daily Drinker
7.060400E-01
Normal-vs-Weekly Drinker
5.217600E-01
Normal-vs-Occasional Drinker
8.120400E-01
Normal-vs-Social Drinker
8.849200E-01
Non Drinker-vs-Daily Drinker
6.249000E-01
Non Drinker-vs-Weekly Drinker
9.336000E-01
Non Drinker-vs-Occasional Drinker
5.170200E-02
Non Drinker-vs-Social Drinker
2.804200E-01
Daily Drinker-vs-Weekly Drinker
7.593800E-01
Daily Drinker-vs-Occasional Drinker
2.441400E-01
Daily Drinker-vs-Social Drinker
6.382600E-01
Weekly Drinker-vs-Occasional Drinker
1.476150E-01
Weekly Drinker-vs-Social Drinker
4.309200E-01
Occasional Drinker-vs-Social Drinker
5.033600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.243400E-01
Normal-vs-Grade 2
9.804000E-02
Normal-vs-Grade 3
7.860200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.447900E-02
Grade 1-vs-Grade 3
8.529900E-02
Grade 1-vs-Grade 4
3.243400E-01
Grade 2-vs-Grade 3
4.984400E-01
Grade 2-vs-Grade 4
9.804000E-02
Grade 3-vs-Grade 4
7.860200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.550400E-01
Normal-vs-NonDiabetic
7.676600E-01
Diabetic-vs-NonDiabetic
4.955200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.104600E-01
Normal-vs-NoPancreatitis
6.611400E-01
Pancreatitis-vs-NoPancreatitis
1.495580E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.442600E-01
Normal-vs-N1
8.919400E-01
N0-vs-N1
8.047200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.084200E-01
Normal-vs-TP53-NonMutant
9.542800E-01
TP53-Mutant-vs-TP53-NonMutant
7.285800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
